The biopharmaceutical industry is surging. But believing that the surge is permanent, or inevitable, would be a mistake. Like other industries, we are buffeted by international […]
Sustained funding and an agile reimbursement system can improve care standards, writes Jim McGrath The reason medicines are reimbursed is that they improve the standard […]
Irish patients deserve faster access to the best new medicines. We are slower than almost every other western European country to give the latest medicines to […]
A quarter of a century ago, almost half of global new treatments originated in Europe. Today, the proportion has dropped to 22%. The United States has […]
Recent figures showing buoyant tax revenues demonstrate the resilience of the economy during the pandemic. As some of the domestic sector struggles, the economy’s overall performance […]
As if Covid-19 wasn’t enough, the health service was hit by a ransomware attack, delaying care for patients across the country. Hackers exposed the vulnerabilities of […]
How much value do innovative medicines generate for the economy? by Bernard Mallee More than a year since the World Health Organisation declared Covid-19 a pandemic, […]
Access to new treatments can be improved by sustainable, predictable Government budgeting, not by weakening intellectual property (IP) rights for medicines development, according to a submission […]
The Astellas plant in Killorglin, Co Kerry, is among the companies that feature in ‘Innovate For Life’ – the IPHA campaign that gives a platform to […]